EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSDCDG00000020911
Gene Symbol: TAAR1
1 Cross references
272 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSDCDG00000020905
Gene Symbol: TAAR1
3 Cross references
540 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1-Like

Ensembl ID : ENSDCDG00000030520
Gene Symbol: LOC114780765
3 Cross references
201 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1-Like

Ensembl ID : ENSDCDG00000002656
Gene Symbol: LOC114787787
3 Cross references
158 Possible Orthologues:

Transmembrane O-Methyltransferase Homolog

Ensembl ID : ENSDCDG00000013772
Gene Symbol: LOC114767854
2 Cross references
177 Possible Orthologues:

Transthyretin

Ensembl ID : ENSDCDG00000031143
Gene Symbol: TTR
3 Cross references
180 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSDCDG00000019305
Gene Symbol: TPH1
3 Cross references
197 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSDCDG00000035083
Gene Symbol: TPH1
3 Cross references
150 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSDCDG00000028487
Gene Symbol: TUBA4A
1 Cross references
103 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSDCDG00000024892
Gene Symbol: LOC114789649
3 Cross references
155 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSDCDG00000021417
Gene Symbol: TUBB1
2 Cross references
184 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSDCDG00000023306
Gene Symbol: TUBB4B
1 Cross references
174 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).